Individual Study / KoCo19

Population-based prospective COVID-19 cohort study Munich, Germany

Population-based prospective COVID-19 cohort study Munich, Germany

Initiatives -
To gain knowledge about the immune status of the population and to better understand the dynamics of the COVID-19 pandemic and to thus appropriately design and evaluate interventions.
Start Year
2020
Funding
Bavarian State Ministry of Science and Art, the LMU Klinikum München and Helmholtz Zentrum München.
Supplementary Information
http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/en/COVID-19/KoCo19/index.html
Visit KoCo19

Members

Download
Investigators Contacts
  • Dr Katja Radon
    LMU University Hospital Munich

Design

Study design
Population cohort
Follow Up
For twelve months, each household member is asked to keep a diary of daily symptoms. For one year, the study teams re-visits the households for blood sampling every six weeks.

Marker Paper

Radon K, Saathoff E, Pritsch M, et al. Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19) [published correction appears in BMC Public Health. 2020 Sep 1;20(1):1335]. BMC Public Health. 2020;20(1):1036. Published 2020 Jun 30. doi:10.1186/s12889-020-09164-9

PUBMED 32605549

Recruitment

Sources of Recruitment
  • Families

Number of participants

Number of participants
3,000
Number of participants with biosamples
Supplementary Information
Munich households.Aged over 14 years old

Access

Availability of data and biosamples

Data
Biosamples
Other